Company Issues Warnings on Popular Weight-Loss Drugs

Be wary of popular weight-loss drugs sold in the United States, Novo Nordisk says.

Prescription drugs on shelves at a pharmacy in Montreal on March 11, 2021. The Canadian Press/Ryan Remiorz

The manufacturer of popular drugs Wegovy and Ozempic warned on Oct. 12 that it has seen a surge of counterfeit versions of its products in recent days.

Novo Nordisk “has seen a significant increase in illegal online sales,” according to a statement, referring to drugs that contain the active ingredient semaglutide.